Research at the University of British Columbia is paving the way for the development of Parkinson's drugs that target the root causes of the disease instead of just treating the symptoms.
A team of researchers at UBC and the Vancouver Coastal Health Research Institute has discovered two genes responsible for the disease in as many months.
A genetically engineered virus selectively infected and killed cancer tissue without harming adjacent normal tissue, results of a phase I clinical study showed.
Avian flu shows signs of a resurgence, while a mutant strain - able to sidestep vaccines - could be spreading in Asia, the United Nations has warned.
A new drug, dubbed "DRACO," or double-stranded RNA Activated Caspase Oligomerizers, works by targeting a type of RNA produced only in virus-infected cells.
Most bacterial infections can be treated with antibiotics such as penicillin, discovered decades ago.
However, such drugs are useless against viral infections, including influenza, the common cold, and deadly hemorrhagic fevers such as Ebola, according to an MIT news release.
Scientists have generated nerve cells from post-mortem human tissue to demonstrate that astrocytes are toxic to neurons in both familial and sporadic forms of amyotrophic lateral sclerosis (ALS). Funded in part by the National Institute of Neurological Disorders and Stroke, the Ohio State University-led team generated astrocytes from post mortem spinal cord neural progenitor cells (NPCs). Their resulting studies indicated that a similar mechanism of astrocyte-mediated toxicity leads to motor neuron death occurs in both FALS and SALS.
More Articles...
- New Leukemia Therapy May be the Greatest Breakthrough in Decades
- Alzheimer’s Disease – New Clues To The Cause Of Alzheimer’s Disease Found
- Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No
- First patients enroll in stem cell trials on blindness
- FDA says chicken can contain small amounts of arsenic
